ADIL•benzinga•
Adial Pharmaceuticals Received Milestone Payment From Adovate Following Initiation Of Phase 1 Study; Adial Eligible To Receive More Than $50M In Commercial Milestone Payments Plus Additional $11M In Development And Approval Milestone Payments Per Compound
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 13, 2025 by benzinga